TY - JOUR
T1 - Engagement of MHC-class II molecules by staphylococcal exotoxins delivers a comitogenic signal to human B cells
AU - Fuleihan, Ramsay
AU - Mourad, Walid
AU - Geha, Raif S.
AU - Chatila, Talal
PY - 1991
Y1 - 1991
N2 - The staphylococcal exotoxin toxic shock syndrome toxin-1 (TSST-1) has been demonstrated to bind to monomorphic determinants on MHC-class II molecules. In this study, we have used TSST-1 to probe the role of MHC-class II molecules in the activation and differentiation of resting human B cells. Highly purified B cells were stimulated with TSST-1, alone or in combination with PMA or with anti-human IgM antibodies (anti-μ) and the resulting B cell proliferation and Ig production were monitored. On its own, TSST-1 failed to induce B cell proliferation or Ig production. However, TSST-1 synergized with PMA and with anti-μ in inducing B cell proliferation in the absence of any added T cells or T cell factors. TSST-1 did not induce or potentiate early activation events associated with anti-μ treatment such as phosphoinositide hydrolysis and Ca2+ mobilization. Also, TSST-1 did not potentiate the capacity of anti-μ to induce the transcription of early activation genes such as c-myc. Finally, in contrast to its capacity to promote mitogen-triggered B cell proliferation, TSST-1 failed to induce the differentiation of B lymphocytes into Ig-secreting cells in the absence of added T cells. These results indicate that TSST-1 delivers a comitogenic signal to B cells via MHC-class II molecules that is distinct from signals delivered via surface μ and further strengthens the role of MHC-class II molecules as signal transducing structures.
AB - The staphylococcal exotoxin toxic shock syndrome toxin-1 (TSST-1) has been demonstrated to bind to monomorphic determinants on MHC-class II molecules. In this study, we have used TSST-1 to probe the role of MHC-class II molecules in the activation and differentiation of resting human B cells. Highly purified B cells were stimulated with TSST-1, alone or in combination with PMA or with anti-human IgM antibodies (anti-μ) and the resulting B cell proliferation and Ig production were monitored. On its own, TSST-1 failed to induce B cell proliferation or Ig production. However, TSST-1 synergized with PMA and with anti-μ in inducing B cell proliferation in the absence of any added T cells or T cell factors. TSST-1 did not induce or potentiate early activation events associated with anti-μ treatment such as phosphoinositide hydrolysis and Ca2+ mobilization. Also, TSST-1 did not potentiate the capacity of anti-μ to induce the transcription of early activation genes such as c-myc. Finally, in contrast to its capacity to promote mitogen-triggered B cell proliferation, TSST-1 failed to induce the differentiation of B lymphocytes into Ig-secreting cells in the absence of added T cells. These results indicate that TSST-1 delivers a comitogenic signal to B cells via MHC-class II molecules that is distinct from signals delivered via surface μ and further strengthens the role of MHC-class II molecules as signal transducing structures.
UR - http://www.scopus.com/inward/record.url?scp=0026100649&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026100649&partnerID=8YFLogxK
M3 - Article
C2 - 1847171
AN - SCOPUS:0026100649
SN - 0022-1767
VL - 146
SP - 1661
EP - 1666
JO - Journal of Immunology
JF - Journal of Immunology
IS - 5
ER -